PIK3CA and central nervous system cancer: On the other hand, samples bearing PIK3CA mutations perturbing the N-terminal SH2 domain of regulatory subunits are associated with poorer prognosis in low grade glioma (p = 1.4e−3, q = 3.79e−2; Table S3a).